Oncovet Clinical Research

Oncovet Clinical Research (OCRvet) operates as a specialized contract research organization (CRO), providing clinical trial services for the development of human and animal health treatments. The company was founded in 2011 by Dominique Tierny, a veterinarian with extensive experience in clinical oncology. Tierny's journey began in 2000 when she established Oncovet, a private referral center for veterinary oncology. Her collaboration with human oncology researchers inspired the creation of OCRvet, driven by a "One Health" concept that connects animal and human well-being.

The firm's core business involves designing and managing clinical trials for pharmaceutical, biotechnology, MedTech, and pet food companies. OCRvet focuses on using companion animals, such as dogs and cats, that have naturally occurring diseases as predictive models for human conditions. This approach is applied across therapeutic areas like oncology, cardiology, neurology, and inflammation. By treating pets with drug candidates intended for human clinical trials, OCRvet offers its clients a method to gain crucial scientific data, potentially optimizing the high costs and reducing the failure rates associated with human drug development. The business model generates revenue by providing these specialized research services, which include preclinical development, regulatory support, data management, and scientific communication. Pet owners also benefit, as their animals gain access to advanced therapies.

OCRvet's service portfolio is comprehensive, covering everything from initial development plans to market launch support. The company leverages a multicenter recruitment network of veterinary clinics across Europe, including France, Poland, Italy, and Portugal, ensuring a strong capacity for conducting studies. Key services include creating study protocols, coordinating investigational sites, and performing data analysis and report writing. OCRvet also maintains a biobank for tissue samples and offers histology and immunohistochemistry preclinical services. A significant milestone occurred in October 2024, when OCRvet was acquired by Clinglobal, a move that enhances its capabilities in field clinical studies for both the animal health and human pharma sectors.

Keywords: contract research organization, comparative medicine, veterinary clinical trials, animal health, human health, drug development, pet clinical trials, oncology research, translational medicine, one health, pharma services, biotech services, medical devices, pet food research, clinical trial management, biobank, histology, in vivo studies, Clinglobal, Dominique Tierny